论文部分内容阅读
目的观察尤瑞克林联合奥扎格雷钠治疗急性脑梗死的疗效及安全性。方法急性脑梗死128例,分成2组,观察组选用尤瑞克林联合奥扎格雷钠治疗;对照组仅选用奥扎格雷钠治疗。两组均给予拜阿司匹林口服及舒血宁静脉滴注。结果观察组与对照组比较,总有效率显著提高(P<0.05),差异具有统计学意义。结论尤瑞克林联合奥扎格雷钠治疗急性脑梗死疗效较好。
Objective To observe the efficacy and safety of uracil combined with ozagrel sodium in the treatment of acute cerebral infarction. Methods 128 cases of acute cerebral infarction were divided into 2 groups. The observation group was treated with irreclarin and ozagrel sodium. The control group was treated with ozagrel sodium only. Both groups were given aspirin orally and Shuxuening intravenous infusion. Results Compared with the control group, the total effective rate was significantly increased (P <0.05), the difference was statistically significant. Conclusion Erilecin combined with ozagrel sodium has a better curative effect on acute cerebral infarction.